Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry

• Main Authors: Lara S. van derSchoot (Author), Hans J. M. M. Groenewoud (Author), Marleen M. H. J. vanGelder (Author), Marisol E. Otero (Author), W. Peter Arnold (Author), Maartje A. M. Berends (Author), Marjolein S. De Bruin‐Weller (Author), Sharon R. P. Dodemont (Author), Marloes M. Kleinpenning (Author), Marjolein I. A. Koetsier (Author), Else N. Kop (Author), John E. M. Körver (Author), Astrid L. A. Kuijpers (Author), Paula P. vanLümig (Author), Johannes M. Mommers (Author), Marcellus D. Njoo (Author), Paul M. Ossenkoppele (Author), Ron A. Tupker (Author), M. Birgitte Visch (Author), Lizelotte J. M. T. Weppner‐Parren (Author), Elke M. G. J. deJong (Author), Juul M. P. A. van denReek (Author)
• Format: Book
• Published: Wiley, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Limited real‐world studies are available comparing infection risk between biologics for psoriasis. Objectives The primary aim was to determine the differential effect of currently available biologics on the risk of respiratory tract infections (RTI) among psoriasis patients in a...